Menu
GWAS Study

Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.

Brandl EJ, Tiwari AK, Zai CC et al.

26323598 PubMed ID
GWAS Study Type
275 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BE
Brandl EJ
TA
Tiwari AK
ZC
Zai CC
NE
Nurmi EL
CN
Chowdhury NI
AT
Arenovich T
SM
Sanches M
GV
Goncalves VF
SJ
Shen JJ
LJ
Lieberman JA
MH
Meltzer HY
KJ
Kennedy JL
MD
Müller DJ
Chapter II

Abstract

Summary of the research findings

Antipsychotic-induced weight gain (AIWG) is a common side effect with a high genetic contribution. We reanalyzed genome-wide association study (GWAS) data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) selecting a refined subset of patients most suitable for AIWG studies. The final GWAS was conducted in N=189 individuals. The top polymorphisms were analyzed in a second cohort of N=86 patients. None of the single-nucleotide polymorphisms was significant at the genome-wide threshold of 5x10(-8). We observed interesting trends for rs9346455 (P=6.49x10(-6)) upstream of OGFRL1, the intergenic variants rs7336345 (P=1.31 × 10(-5)) and rs1012650 (P=1.47 × 10(-5)), and rs1059778 (P=1.49x10(-5)) in IBA57. In the second cohort, rs9346455 showed significant association with AIWG (P=0.005). The combined meta-analysis P-value for rs9346455 was 1.09 × 10(-7). Our reanalysis of the CATIE GWAS data revealed interesting new variants associated with AIWG. As the functional relevance of these polymorphisms is yet to be determined, further studies are needed.The Pharmacogenomics Journal advance online publication, 1 September 2015; doi:10.1038/tpj.2015.59.

189 European ancestry treated schizophrenia cases

Chapter III

Study Statistics

Key metrics and study information

275
Total Participants
GWAS
Study Type
Yes
Replicated
86 European ancestry treated schizophrenia or schizoaffective cases
Replication Participants
European
Ancestry
U.S., Germany
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.